Exercise and Parkinson's disease

Int Rev Neurobiol. 2019:147:45-74. doi: 10.1016/bs.irn.2019.06.003. Epub 2019 Jun 20.

Abstract

Parkinson's disease (PD) is one of the most common neurodegenerative diseases in the world. Unfortunately, most of the currently used clinical therapies against PD are symptomatic and there is still no remedy can stop disease progression. Collective evidence shows that various kinds of exercise may reduce the risk of PD and do have positive impacts on both motor and nonmotor symptoms of PD. Additionally, exercise can also ameliorate the side effects such as wearing-off and dyskinesia induced by anti-PD therapeutics. In parallel with its benefits in ameliorating clinical symptoms, exercise modulates a range of supporting systems for brain maintenance and plasticity including neurogenesis, synaptogenesis, enhanced metabolism and angiogenesis. Exercise provides all these broad benefits on PD through inhibiting oxidative stress, repairing mitochondrial damage, and promoting the production of growth factors. Moreover, exercise reduces risk of other geriatric diseases such as diabetes, hypertension and cardiovascular disease, which may also contribute to PD pathogenesis. In summary, exercise is increasingly considered to be a complementary strategy to PD medications. In this chapter, we summarize the recent research progress on the beneficial effects of exercise on PD, discuss the underlying mechanisms, and highlight the promising prospects of exercise for antiparkinsonian therapy.

Keywords: Brain health; Drug interaction; Exercise; Neurotrophic factor; Parkinson's disease; Rehabilitation.

Publication types

  • Review

MeSH terms

  • Animals
  • Disease Models, Animal
  • Exercise / physiology*
  • Exercise Therapy*
  • Humans
  • Parkinson Disease / physiopathology*
  • Parkinson Disease / prevention & control
  • Parkinson Disease / therapy*
  • Physical Conditioning, Animal / physiology